Cytogenetic abnormalities in adult non-promyelocytic acute myeloid leukemia: A concise review
作者： Francesco Marchesi , Ombretta Annibali , Elisabetta Cerchiara , Maria Cristina Tirindelli , Giuseppe Avvisati
DOI: 10.1016/J.CRITREVONC.2010.11.006
关键词:
摘要: Abstract Cytogenetic abnormalities are found in 50–60% of newly diagnosed acute myeloid leukemia (AML) adult patients. analysis bone marrow leukemic cells is an important pre-treatment evaluation for a correct prognostic stratification patients, that permit to separate AML patients three broad categories: high, intermediate and low risk. The determination cytogenetic features remains corner stone predicting outcome although today its use needs be integrated by molecular immunophenotypic data, particularly cytogenetically normal (CN) group In this review we perform concise description more recurrent aberrations AML, theirs correlations with biological clinical data strong impact useful therapeutic decision.
elsevier.com
hemepathreview.com 参考文章(105)
Randa Alsabeh, Russell K. Brynes, Marilyn L. Slovak, Daniel A. Arber, Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype. American Journal of Clinical Pathology. ,vol. 107, pp. 430- 437 ,(1997) , 10.1093/AJCP/107.4.430
Peter Beighton, Greta Beighton, de la Chapelle, A. The Person Behind the Syndrome. pp. 209- 209 ,(1997) , 10.1007/978-1-4471-0925-9_118
Ju Yan, Danièle Marceau, Régen Drouin, Tetrasomy 8 is associated with a major cellular proliferative advantage and a poor prognosis Cancer Genetics and Cytogenetics. ,vol. 125, pp. 14- 20 ,(2001) , 10.1016/S0165-4608(00)00352-6
H Hasle, , M Aricò, G Basso, A Biondi, A Cantù Rajnoldi, U Creutzig, S Fenu, C Fonatsch, OA Haas, J Harbott, G Kardos, G Kerndrup, G Mann, CM Niemeyer, H Ptoszkova, J Ritter, R Slater, J Starý, B Stollmann-Gibbels, AM Testi, ER van Wering, M Zimmermann, Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS). Leukemia. ,vol. 13, pp. 376- 385 ,(1999) , 10.1038/SJ.LEU.2401342
ER Levy, E Parganas, K Morishita, S Fichelson, L James, D Oscier, S Gisselbrecht, JN Ihle, VJ Buckle, DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome Blood. ,vol. 83, pp. 1348- 1354 ,(1994) , 10.1182/BLOOD.V83.5.1348.1348
Marilyn L. Slovak, Kenneth J. Kopecky, Peter A. Cassileth, David H. Harrington, Karl S. Theil, Anwar Mohamed, Elizabeth Paietta, Cheryl L. Willman, David R. Head, Jacob M. Rowe, Stephen J. Forman, Frederick R. Appelbaum, Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study Blood. ,vol. 96, pp. 4075- 4083 ,(2000) , 10.1182/BLOOD.V96.13.4075
David Grimwade, Helen Walker, Fiona Oliver, Keith Wheatley, Christine Harrison, Georgina Harrison, John Rees, Ian Hann, Richard Stevens, Alan Burnett, Anthony Goldstone, The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial Blood. ,vol. 92, pp. 2322- 2333 ,(1998) , 10.1182/BLOOD.V92.7.2322
Melina Carapeti, Ricardo C.T. Aguiar, John M. Goldman, Nicholas C.P. Cross, A Novel Fusion Between MOZ and the Nuclear Receptor Coactivator TIF2 in Acute Myeloid Leukemia Blood. ,vol. 91, pp. 3127- 3133 ,(1998) , 10.1182/BLOOD.V91.9.3127.3127_3127_3133
Giovanna Rege-Cambrin, Anne Hagemeijer, Emilia Giugliano, Patrizia Scaravaglio, Michel Stul, Lucienne Michaux, Giuseppe Saglio, Anna Serra, Trisomy 11 in myeloid malignancies is associated with internal tandem duplication of both MLL and FLT3 genes. Haematologica. ,vol. 90, pp. 262- 264 ,(2005) , 10.3324/%X
John C. Byrd, Richard K. Dodge, Andrew Carroll, Maria R. Baer, Colin Edwards, Judith Stamberg, Mazin Qumsiyeh, Joseph O. Moore, Robert J. Mayer, Frederick Davey, Charles A. Schiffer, Clara D. Bloomfield, Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered Journal of Clinical Oncology. ,vol. 17, pp. 3767- 3775 ,(1999) , 10.1200/JCO.1999.17.12.3767